Summary

This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Plavix -Drug Insights, 2017

Description

“Plavix- Drug Insights, 2017” highlights the Plavix marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment of the Plavix covering the total sales estimation and also provides the Plavix sales performance during the historical period and forecast period to 2018. Report also covers the detailed clinical assessment of Plavix, patents information and exclusivity data, route of synthesis, competitive landscape, and generic players. In addition to this, Report provides the SWOT analysis for the Plavix.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/233655 .

Scope

  • A review of the Plavix based on information derived from company and industry-specific sources
  • Coverage of the Marketed data of the Plavix on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Plavix with location details
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Global Forecasted Sales Figure to 2018
  • Qualitative and quantitative assessment of market space
  • SWOT Analysis

Reasons to buy

  1. Evaluate the marketing status and exclusivity details of Plavix to exploit opportunities for generic drug development opportunities.
  2. Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Plavix.
  3. API intelligence over Plavix and gaining primary intelligence over Active Ingredients manufacturers across the globe.
  4. Understanding the chemical route of synthesis of Plavix.
  5. Uncovering opportunities in the rapidly growing the US market
  6. Stay ahead of competition by understanding the changing competitive landscape
  7. Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  8. Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
  9. Obtain sales forecast for currently marketed drug for to 2018No. of Report Pages: 100

Purchase a copy of this report @  http://www.orbisresearch.com/contact/purchase/233655 .

  1. Report Introduction
  2. Plavix Overview
    2.1 Market Competition
    2.3 Competitors in Development

3 Global Sales Assessment
3.1 Historical Sales of Plavix
3.2 Forecasted Sales of Plavix

4 Product Description
4.1 Mechanism of Action
4.2 Pharmacodynamic Properties
4.3 Pharmacokinetic Properties

5 Marketed Details
5.1 United States
5.2 Europe

6 Patent Information
6.1 Patent Numbers and Expiry Details
6.2 Patent and Exclusivity Expiry Assessment United States (US)
6.3 Patent Details

7 Route of Synthesis

8 Global API Manufacturers Assessment
8.1 The United States Drug Master File (US DMF)
8.2 The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
8.3 The Active Pharmaceutical Ingredient (API) Manufacturers in China
8.4 The Active Pharmaceutical Ingredient (API) Manufacturers in India

9 Generic Players

10 The Pipeline Coverage

11 Clinical Trials Information
11.1 Clinical Trials by Zone

12 Company Profile
12.1 Company Summary
12.2 Company Financials

13 SWOT Analysis

14 References

15 Appendix

16 Methodology

17 Consulting Services

18 About

19 Contact Us

20 Disclaimer

Got any Query? Feel free to ask us at : http://www.orbisresearch.com/contacts/enquiry-before-buying/233655

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

For more information contact sales@orbisresearch.com

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s